US 8,796,222 B2Granted

Suspensions of cyclosporin A form 2

AssigneeAllergan, Inc.

InventorsAnuradha Gore, Prem Swaroop Mohanty, E. Quinn Farnes

Life of this patent

Estimating the term…

Disclosed herein are methods of formulating cyclosporin A Form 2.

Dependent claims

A formulation comprising

Dependencies are inferred from the claim text.

A61K 38/13
Cyclic peptides , e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C: cyclosporins
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears
A61K 9/14
Medicinal preparations characterised by special physical form: particulate form, e.g. powders, Processes for size reducing of pure drugs or the…

From the US filing history. Foreign family members aren’t listed.

Loading patent…